Barr Laboratories, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barr Laboratories, Inc..The latest application filed is for "transdermal dosage form".

Company Profile

0.14.11

Barr Laboratories, Inc. - Pomona NY US
Barr Laboratories, Inc. - Woodcliffe Lake NJ
Barr Laboratories, Inc. - Woodcliff Lake NJ
Barr Laboratories, Inc. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Transdermal Dosage Form App 20180303827 - Tang; John ; et al.	2018-10-25
Transdermal dosage form Grant 10,010,543 - Tang , et al. July 3, 2	2018-07-03
Treatment of conditions relating to hormone deficiencies by administration of progestins Grant 8,076,319 - Leonard December 13, 2	2011-12-13
Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same Grant 7,811,604 - Ahmed , et al. October 12, 2	2010-10-12
Treatment of conditions relating to hormone deficiencies by administration of progestins Grant 7,683,047 - Leonard March 23, 2	2010-03-23
Treatment Of Conditions Relating To Hormone Deficiencies By Administration Of Progestins App 20080300224 - Leonard; Thomas W.	2008-12-04
Treatment of conditions relating to hormone deficiencies by administration of progestins Grant 7,427,609 - Leonard September 23, 2	2008-09-23
Ondansetron orally disintegrating tablets Grant 7,390,503 - Ahmed , et al. June 24, 2	2008-06-24
Process for the production of 2-oxa-3-one androstane derivatives Grant 7,297,801 - Ponder November 20, 2	2007-11-20
Bisphosphonate composition and process for the preparation thereof App 20070218130 - Ahmed; Salah U. ; et al.	2007-09-20
Novel Estrogenic Compounds App 20070142307 - Hill; Edward N. ; et al.	2007-06-21
(3) and (6) substituted estrogenic compounds Grant 7,179,799 - Hill , et al. February 20, 2	2007-02-20
Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy App 20060154907 - Leonard; Thomas W. ; et al.	2006-07-13
Process for the production of oxandrolone Grant 7,009,063 - Desai , et al. March 7, 2	2006-03-07
Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex App 20060041151 - Leonard; Thomas W.	2006-02-23
C(14) estrogenic compounds Grant 6,992,075 - Hill , et al. January 31, 2	2006-01-31
Process for the production of oxandrolone App 20050004376 - Desai, Shaileshkumar Ramanlal ; et al.	2005-01-06
Surface-treated modafinil particles App 20040253308 - Ahmed, Salah U. ; et al.	2004-12-16
Kit for pharmaceuticals App 20040222123 - Niemann, Amy C.	2004-11-11
Process for the production of oxandrolone Grant 6,787,659 - Desai , et al. September 7, 2	2004-09-07
Bisphosphonate composition and process for the preparation thereof App 20040138180 - Ahmed, Salah U. ; et al.	2004-07-15
Method for treating osteoporosis in castrated prostatic cancer patients Grant 6,613,758 - Bell September 2, 2	2003-09-02
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology App 20030139381 - Bell, Robert G. ; et al.	2003-07-24
Method of administering a narcotic analgesic and dosage forms therefor Grant 4,973,596 - Cohen November 27, 1	1990-11-27

Company Registrations

NCAGE Code	56490	BARR LABORATORIES, INC.
NCAGE Code	9K643	BARR LABORATORIES INC
CAGE Code	56490	BARR LABORATORIES, INC.
CAGE Code	9K643	BARR LABORATORIES INC
S.A.M. Registration	56490 [56306780]	BARR LABORATORIES, INC.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.